의약품용 젤라틴 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 공급원별, 기능별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Source, By Function, By End User, By Region and Competition, 2020-2030F
의약품용 젤라틴 세계 시장은 2024년에 18억 9,000만 달러로 평가되며, 2030년에는 연평균 5.51%의 CAGR을 기록하며 26억 1,000만 달러에 달할 것으로 예상됩니다.
제약용 젤라틴은 생체적합성과 엄격한 안전 및 순도 기준을 충족하는 능력으로 인해 캡슐, 정제, 지혈제 등 의약품 제제에 널리 사용되는 중요한 부형제입니다. 동물성 콜라겐을 주원료로 하는 의약품용 젤라틴은 병원균, 알레르겐, 유해물질이 포함되지 않도록 멸균, 정제 등 엄격한 과정을 거쳐야 합니다. 약물의 안정성, 생체 이용률, 환자 순응도를 향상시키는 일관된 성능으로 다양한 치료 용도에 필수적인 역할을 하고 있습니다. 지역적 선호도 및 규제 지침에 따라 소, 돼지, 생선, 닭 등 동물성 젤라틴의 원료가 결정되는 경우가 많습니다. 경구용 제형에 대한 수요 증가와 의약품 제조 기술 발전으로 인해 세계 시장 확대가 지속되고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
18억 9,000만 달러 |
| 시장 규모 : 2030년 |
26억 1,000만 달러 |
| CAGR : 2025-2030년 |
5.51% |
| 급성장 부문 |
소프트 캡슐 |
| 최대 시장 |
북미 |
시장 촉진요인
제약 산업의 성장
주요 시장 과제
원자재 공급 및 가격 변동
주요 시장 동향
식물성 대체품으로의 전환
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유형별(A형, B형)
- 원료별(돼지, 우피, 우골, 생선, 가금류)
- 기능별(안정화, 증점, 겔화, 기타)
- 최종사용자별(하드 캡슐, 소프트 캡슐, 태블릿, 흡수성 지혈제, 기타)
- 기업별(2024년)
- 지역별
- 시장 맵
제6장 북미의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 의약품용 젤라틴 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
제13장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 능력
- 고객의 능력
- 대체품의 위협
제14장 경쟁 구도
- Gelita AG
- Trobas Pharmaceutical gelatine B.V
- Rousselot SAS
- Gelatines Weishardt SAS
- Sterling Biotec Ltd.
- Catalent, Inc
- Nitta Pharmaceutical Gelatin India Limited
- Aspire Pharmaceuticals
- Gelco International
- Lapi Gelatine S.p.a
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
The Global Pharmaceutical Gelatin Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.61 billion by 2030, registering a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards. Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin-whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.89 Billion |
| Market Size 2030 | USD 2.61 Billion |
| CAGR 2025-2030 | 5.51% |
| Fastest Growing Segment | Soft Capsule |
| Largest Market | North America |
Key Market Drivers
Growing Pharmaceutical Industry
The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin's functional versatility is expected to further solidify its market position.
Key Market Challenges
Raw Material Supply and Price Volatility
The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.
Key Market Trends
Shift Towards Plant-Based Alternatives
The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions. Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.
Key Market Players
- Gelita AG
- Trobas Pharmaceutical gelatine B.V
- Rousselot SAS
- Gelatines Weishardt SAS
- Sterling Biotec Ltd.
- Catalent, Inc
- Nitta Pharmaceutical Gelatin India Limited
- Aspire Pharmaceuticals
- Gelco International
- Lapi Gelatine S.p.a
Report Scope:
In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pharmaceutical Gelatin Market, By Type:
Pharmaceutical Gelatin Market, By Source:
- Porcine
- Bovine Skin
- Bovine Bone
- Fish
- Poultry
Pharmaceutical Gelatin Market, By Function:
- Stabilizing
- Thickening
- Gelling
- Others
Pharmaceutical Gelatin Market, By End User:
- Hard Capsule
- Soft Capsule
- Tablet
- Absorbable Hemostat
- Others
Pharmaceutical Gelatin Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Pharmaceutical Gelatin Market.
Available Customizations:
Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Pharmaceutical Gelatin Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Type A, Type B)
- 5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
- 5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
- 5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
- 5.3. Market Map
6. North America Pharmaceutical Gelatin Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Source
- 6.2.3. By Function
- 6.2.4. By End User
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Pharmaceutical Gelatin Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Source
- 6.3.1.2.3. By Function
- 6.3.1.2.4. By End User
- 6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Source
- 6.3.2.2.3. By Function
- 6.3.2.2.4. By End User
- 6.3.3. Canada Pharmaceutical Gelatin Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Source
- 6.3.3.2.3. By Function
- 6.3.3.2.4. By End User
7. Europe Pharmaceutical Gelatin Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Source
- 7.2.3. By Function
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Pharmaceutical Gelatin Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Source
- 7.3.1.2.3. By Function
- 7.3.1.2.4. By End User
- 7.3.2. Germany Pharmaceutical Gelatin Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Source
- 7.3.2.2.3. By Function
- 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Source
- 7.3.3.2.3. By Function
- 7.3.3.2.4. By End User
- 7.3.4. Italy Pharmaceutical Gelatin Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Source
- 7.3.4.2.3. By Function
- 7.3.4.2.4. By End User
- 7.3.5. Spain Pharmaceutical Gelatin Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Source
- 7.3.5.2.3. By Function
- 7.3.5.2.4. By End User
8. Asia-Pacific Pharmaceutical Gelatin Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Source
- 8.2.3. By Function
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Pharmaceutical Gelatin Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Source
- 8.3.1.2.3. By Function
- 8.3.1.2.4. By End User
- 8.3.2. India Pharmaceutical Gelatin Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Source
- 8.3.2.2.3. By Function
- 8.3.2.2.4. By End User
- 8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Source
- 8.3.3.2.3. By Function
- 8.3.3.2.4. By End User
- 8.3.4. Japan Pharmaceutical Gelatin Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Source
- 8.3.4.2.3. By Function
- 8.3.4.2.4. By End User
- 8.3.5. Australia Pharmaceutical Gelatin Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Source
- 8.3.5.2.3. By Function
- 8.3.5.2.4. By End User
9. South America Pharmaceutical Gelatin Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Source
- 9.2.3. By Function
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Source
- 9.3.1.2.3. By Function
- 9.3.1.2.4. By End User
- 9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Source
- 9.3.2.2.3. By Function
- 9.3.2.2.4. By End User
- 9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Source
- 9.3.3.2.3. By Function
- 9.3.3.2.4. By End User
10. Middle East and Africa Pharmaceutical Gelatin Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Source
- 10.2.3. By Function
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Source
- 10.3.1.2.3. By Function
- 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Source
- 10.3.2.2.3. By Function
- 10.3.2.2.4. By End User
- 10.3.3. UAE Pharmaceutical Gelatin Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Source
- 10.3.3.2.3. By Function
- 10.3.3.2.4. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Porters Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Gelita AG
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Trobas Pharmaceutical gelatine B.V
- 14.3. Rousselot SAS
- 14.4. Gelatines Weishardt SAS
- 14.5. Sterling Biotec Ltd.
- 14.6. Catalent, Inc
- 14.7. Nitta Pharmaceutical Gelatin India Limited
- 14.8. Aspire Pharmaceuticals
- 14.9. Gelco International
- 14.10. Lapi Gelatine S.p.a
15. Strategic Recommendations
16. About Us & Disclaimer
